when did the first glp 1 come out GLP-1R Agonists for Weight Loss A Brief History of GLP-1

Marc Ronert originally initiated the development of a product to counteract the undesirable volume loss in the face that occurs with rapid weight loss

Adults with type 2 diabetes assigned an SGLT2 inhibitor or a GLP-1 receptor agonist during cardiovascular outcomes trials derived benefit from the therapies regardless of whether they were prescribed insulin, according to a meta-analysis.In an analysis of data across eight large, multiyear CV outcomes trials for three classes of diabetes agents, researchers also found that participants using

This promotes microbial diversity, enhances short-chain fatty acid production, supports gut barrier integrity, and helps create a balanced, thriving microbiome for optimal digestive and immune health

The data were analyzed using both mean differences (MDs) and standardized mean differences (SMDs) with 95% CIs and odds ratios (ORs) with 95% CIs